Brown Brothers Harriman & CO Bristol Myers Squibb CO Transaction History
Brown Brothers Harriman & CO
- $13.6 Billion
- Q4 2024
A detailed history of Brown Brothers Harriman & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 80,832 shares of BMY stock, worth $4.36 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
80,832
Previous 86,429
6.48%
Holding current value
$4.36 Million
Previous $4.47 Million
2.21%
% of portfolio
0.03%
Previous 0.03%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,741Shares Held
1.57BCall Options Held
28.2MPut Options Held
29.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...